AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed), represents over 70 manufacturers of innovative in vitro diagnostic (IVD) tests in the U.S. and abroad. AdvaMedDx seeks to advance policy to promote innovation and expand access to quality testing.

Across the health care delivery system, diagnostic tests are critical for the day-to-day evidence-based care of all patients by enabling early detection of disease, aiding in the determination of the most appropriate clinical pathway for patient care, and increasingly supporting the practice of precision or personalized medicine to improve the health and health care of all patients.